FidoCure Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $15M

  • Investors
  • 28

FidoCure General Information

Description

Developer of an AI-driven precision medicine platform designed for canine cancer treatment. The company leverages next-generation sequencing and clinical data to analyze naturally occurring canine cancers, maintaining a proprietary database for cancer analysis, and provides genomic sequencing services and targeted therapy recommendations for dogs with cancer to deliver precision medicine solutions that improve treatment outcomes, enabling veterinarians to deliver personalized treatment plans that address the unique characteristics of each dog's cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 530 Lytton Avenue
  • 2nd Floor
  • Palo Alto, CA 94301
  • United States
+1 (415)
Primary Industry
Other Healthcare Services
Corporate Office
  • 530 Lytton Avenue
  • 2nd Floor
  • Palo Alto, CA 94301
  • United States
+1 (415)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

FidoCure Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series B) 01-Jan-2024 $15M Completed Generating Revenue
9. Later Stage VC 01-Mar-2022 Completed Generating Revenue
8. Later Stage VC (Series A) 31-Mar-2021 Completed Generating Revenue
7. Seed Round 23-Jan-2019 Completed Generating Revenue
6. Seed Round 31-Oct-2018 Completed Generating Revenue
5. Secondary Transaction - Private 17-May-2018 Completed Generating Revenue
4. Debt - General Completed Generating Revenue
3. Accelerator/Incubator 20-Mar-2018 Completed Generating Revenue
2. Accelerator/Incubator 16-Jun-2017 $50K $1.3M Completed Generating Revenue
1. Seed Round 01-Mar-2017 $1.25M $1.25M Completed Generating Revenue
To view FidoCure’s complete valuation and funding history, request access »

FidoCure Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed
To view FidoCure’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

FidoCure Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an AI-driven precision medicine platform designed for canine cancer treatment. The company leverages next-g
Other Healthcare Services
Palo Alto, CA
19 As of 2026

Tustin, CA
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

FidoCure Competitors (1)

One of FidoCure’s competitors is Veterinarian Cancer Group, a Corporation company based in Tustin, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Veterinarian Cancer Group Corporation Tustin, CA
You’re viewing 1 of 1 competitors. Get the full list »

FidoCure Patents

FidoCure Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024380219-A1 Treatment of canine cancers Pending 16-Nov-2023
EP-4808545-A1 Treatment of canine cancers Pending 16-Nov-2023
US-20260325515-A1 Treatment of canine cancers Pending 16-Nov-2023
WO-2025106908-A1 Treatment of canine cancers Inactive 16-Nov-2023
CA-3149796-A1 Anti-cancer agents for the treatment of canine cancers Pending 02-Aug-2019 A61K41/00
To view FidoCure’s complete patent history, request access »

FidoCure Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

FidoCure Investors (28)

Investor Name Investor Type Holding Investor Since Participating Rounds
Exitfund Venture Capital Minority
Gaingels Venture Capital Minority
Ligo Partners Family Office Minority
MyAsiaVC Venture Capital Minority
Strategxy Ventures Venture Capital Minority
You’re viewing 5 of 28 investors. Get the full list »

FidoCure FAQs

  • When was FidoCure founded?

    FidoCure was founded in 2016.

  • Where is FidoCure headquartered?

    FidoCure is headquartered in Palo Alto, CA.

  • What is the size of FidoCure?

    FidoCure has 19 total employees.

  • What industry is FidoCure in?

    FidoCure’s primary industry is Other Healthcare Services.

  • Is FidoCure a private or public company?

    FidoCure is a Private company.

  • What is FidoCure’s current revenue?

    The current revenue for FidoCure is .

  • How much funding has FidoCure raised over time?

    FidoCure has raised $32.1M.

  • Who are FidoCure’s investors?

    Exitfund, Gaingels, Ligo Partners, MyAsiaVC, and Strategxy Ventures are 5 of 28 investors who have invested in FidoCure.

  • Who are FidoCure’s competitors?

    Veterinarian Cancer Group is a competitor of FidoCure.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process